<?xml version="1.0" encoding="UTF-8"?>
<modsCollection xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
  <mods>
    <titleInfo>
      <title>Effects of administration of iron, iodine and simultaneous iron-plus-iodine on the thyroid hormone profile in iron-deficient adolescent Iranian girls</title>
    </titleInfo>
    <name type="personnal">
      <namePart type="family">Eftekhari</namePart>
      <namePart type="given">M.H.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Simondon</namePart>
      <namePart type="given">Kirsten</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Jalali</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Keshavarz</namePart>
      <namePart type="given">S.A.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Elguero</namePart>
      <namePart type="given">Eric</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Eshraghian</namePart>
      <namePart type="given">M.R.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <name type="personnal">
      <namePart type="family">Saadat</namePart>
      <namePart type="given">N.</namePart>
      <role>
        <roleTerm type="text">auteur</roleTerm>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
      <affiliation>IRD</affiliation>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <language>
      <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <physicalDescription>
      <internetMediaType>text/pdf</internetMediaType>
      <digitalOrigin>born digital</digitalOrigin>
      <reformattingQuality>access</reformattingQuality>
    </physicalDescription>
    <abstract>Objective: To investigate whether iron supplementation can improve thyroid hormone function in iron-deficient adolescent girls. Design: A double-blind randomized intervention study. Setting: The study was performed from 2002 through 2003 in the Islamic Republic of Iran. Subjects: 103 iron-deficient non-anaemic girls who fulfilled all inclusion criteria were included, and 94 subjects successfully completed the study. Interventions: Patients were randomly assigned to one of four groups and treated with a single oral dose of 190 mg iodine plus 300 mg ferrous sulphate 5 times/week (n = 24), 300 mg ferrous sulphate 5 times/week (n = 23), a single oral dose of 190 mg iodine ( n 25), or a placebo ( n 22) for 12 weeks. Results: All groups were comparable at baseline. After the intervention, there was a significant increase in ferritin and transferrin saturation in the iron + iodine group (17.6 vs 8.7 mu g/dl, and 18.8 vs 7.2%, respectively, P&lt;0.001 for both) and in the iron group (P&lt;0.001 for both). Urinary iodine doubled in the iron + iodine group and in the iodine group ( P&lt;0.001 for both). Thyroid indices tT4, tT3 and T3RU increased and reverse RT3 decreased in the iron + iodine group ( 10 vs 8.9 mu g/dl, P&lt; 0.001; 143 vs 138 mu g/dl, P&lt;0.05; 32.3 vs 28.4%, P&lt;0.001 and 24.8 vs 44.2 ng/dl, P&lt;0.001, respectively) and in the iron group. These two groups did not differ for any of the four indices, but both differed significantly from the iodine and placebo groups. Conclusions: Our results indicate that improvement of iron status was accompanied by an improvement in some indices of thyroid hormones.</abstract>
    <targetAudience authority="marctarget">specialized</targetAudience>
    <subject authority="local">
      <topic>FER</topic>
      <topic>ANEMIE</topic>
      <topic>DEFICIENCE</topic>
      <topic>SUPPLEMENTATION</topic>
      <topic>HORMONE</topic>
      <topic>ADOLESCENT</topic>
      <topic>CONSOMMATION ALIMENTAIRE</topic>
      <topic>ANALYSE STATISTIQUE</topic>
      <topic>ETUDE COMPARATIVE</topic>
    </subject>
    <subject>
      <topic>IODE</topic>
      <topic>FERRITINE</topic>
      <topic>GLANDE THYROIDE</topic>
      <topic>SULFATE DE FER</topic>
    </subject>
    <subject>
      <topic>iron</topic>
      <topic>ferritin</topic>
      <topic>thyroid hormones</topic>
      <topic>supplementation trial</topic>
      <topic>micronutrients</topic>
    </subject>
    <subject authority="local">
      <geographic>IRAN</geographic>
    </subject>
    <classification authority="local">054PHYMED02</classification>
    <relatedItem type="host">
      <titleInfo>
        <title>European Journal of Clinical Nutrition</title>
      </titleInfo>
      <part>
        <detail type="volume">
          <number>60</number>
        </detail>
        <detail type="volume">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <list> 545-552</list>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">0954-3007</identifier>
    </relatedItem>
    <identifier type="uri">https://www.documentation.ird.fr/hor/fdi:010035615</identifier>
    <identifier type="doi">10.1038/sj.ejcn.1602349</identifier>
    <identifier type="issn">0954-3007</identifier>
    <location>
      <shelfLocator>[F B010035615]</shelfLocator>
      <url usage="primary display" access="object in context">https://www.documentation.ird.fr/hor/fdi:010035615</url>
      <url access="row object">https://www.documentation.ird.fr/intranet/publi/2006/05/010035615.pdf</url>
    </location>
    <accessCondition type="restriction access" displayLabel="Accès réservé">Accès réservé (Intranet de l'IRD)</accessCondition>
    <recordInfo>
      <recordContentSource>IRD - Base Horizon / Pleins textes</recordContentSource>
      <recordCreationDate encoding="w3cdtf">2006-05-30</recordCreationDate>
      <recordChangeDate encoding="w3cdtf">2017-08-23</recordChangeDate>
      <recordIdentifier>fdi:010035615</recordIdentifier>
      <languageOfCataloging>
        <languageTerm authority="iso639-2b">fre</languageTerm>
      </languageOfCataloging>
    </recordInfo>
  </mods>
</modsCollection>
